Epidemiological Study on Case Definition of Methicillin-Resistant Staphylococcus aureus Enteritis
- PMID: 38854779
- PMCID: PMC11162192
- DOI: 10.2147/IDR.S459708
Epidemiological Study on Case Definition of Methicillin-Resistant Staphylococcus aureus Enteritis
Abstract
Background: Methicillin-resistant Staphylococcus aureus (MRSA) enteritis is a condition in which MRSA grows abnormally in the intestine after administration of antimicrobial agents, resulting in enteritis. Patients with MRSA detected in stool culture tests are often diagnosed with MSRA enteritis. However, uncertainty remains in the diagnostic criteria; therefore, we conducted epidemiological studies to define these cases.
Patients and methods: Patients who tested positive for MRSA by stool culture using selective media 48 h after admission to Kochi Medical School Hospital between April 1, 2012, and December 31, 2022, and did not meet the exclusion criteria were included. We defined MRSA enteritis (Group A) as cases that were responsive to treatment with vancomycin hydrochloride powder, had a Bristol Stool Scale of ≥ 5, and a stool frequency of at least three times per day; all others were MRSA carriers (Group B). Multivariate analysis was performed to risk factors associated with MRSA enteritis.
Results: Groups A and B included 18 (25.4%) and 53 (74.6%) patients, respectively. Multivariate logistic regression analysis showed that a white blood cell count of > 10000/µL (odds ratio [OR], 5.50; 95% confidence interval [CI], 1.12-26.9), MRSA count of ≥ 2+ in stool cultures (OR, 8.91; 95% CI, 1.79-44.3), and meropenem administration within 1 month of stool specimen submission (OR, 7.47; 95% CI, 1.66-33.6) were risk factors of MRSA enteritis.
Conclusion: The case definitions reviewed for MRSA enteritis may be useful as diagnostic criteria.
Keywords: MRSA counts in stool cultures; MRSA enteritis; diagnostic criteria; meropenem; white blood cell.
© 2024 Yagi et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Similar articles
-
[Analysis on risk factors of methicillin-resistant staphylococcus aureus enterocolitis after gastrointestinal surgery].Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Dec 25;21(12):1387-1390. Zhonghua Wei Chang Wai Ke Za Zhi. 2018. PMID: 30588590 Chinese.
-
A case report of postoperative VRSA enteritis: Effective management of rifampicin for vancomycin resistant Staphylococcus aureus enteritis after esophagectomy and colon reconstruction.Int J Surg Case Rep. 2018;52:75-78. doi: 10.1016/j.ijscr.2018.08.038. Epub 2018 Aug 24. Int J Surg Case Rep. 2018. PMID: 30321829 Free PMC article.
-
Oral vancomycin hydrochloride therapy for postoperative methicillin-cephem-resistant Staphylococcus aureus enteritis.Surg Today. 1997;27(9):826-32. doi: 10.1007/BF02385273. Surg Today. 1997. PMID: 9306605 Clinical Trial.
-
Epidemiology of clinically isolated methicillin-resistant Staphylococcus aureus (MRSA) and its susceptibility to linezolid and vancomycin in Egypt: a systematic review with meta-analysis.BMC Infect Dis. 2023 Apr 26;23(1):263. doi: 10.1186/s12879-023-08202-2. BMC Infect Dis. 2023. PMID: 37101125 Free PMC article.
-
Prevalence, predictors, and mortality of bloodstream infections due to methicillin-resistant Staphylococcus aureus in patients with malignancy: systemic review and meta-analysis.BMC Infect Dis. 2021 Jan 14;21(1):74. doi: 10.1186/s12879-021-05763-y. BMC Infect Dis. 2021. PMID: 33446122 Free PMC article.
References
-
- Iwai S, Sato T, Kunimatsu M, et al. Hospital acquired infection in surgical field and its countermeasure present situation of anaerobes, P. aeruginosa and MRSA infection. Nihon Geka Gakkai Zasshi. 1992;93:906–909. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous